Co-Authors
This is a "connection" page, showing publications co-authored by Markus Weigand and Dirk Jäger.
Connection Strength
0.057
-
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 06; 21(1):828.
Score: 0.057